The store will not work correctly when cookies are disabled.
3-((4-(5-bromo-2-methoxyphenyl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)amino)benzonitrile
ID: ALA4856751
PubChem CID: 164611904
Max Phase: Preclinical
Molecular Formula: C18H12BrN3O3
Molecular Weight: 398.22
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(Br)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O
Standard InChI: InChI=1S/C18H12BrN3O3/c1-25-14-6-5-11(19)8-13(14)15-16(18(24)22-17(15)23)21-12-4-2-3-10(7-12)9-20/h2-8H,1H3,(H2,21,22,23,24)
Standard InChI Key: PJQXOWLFWLVNJN-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
19.0750 -22.3480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8922 -22.3480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1466 -21.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4836 -21.0892 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8249 -21.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6505 -23.0463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8312 -23.0264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4062 -23.7249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7993 -24.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6218 -24.4597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0432 -23.7606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3718 -23.0097 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1851 -23.0093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5902 -23.7157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4028 -23.7157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8099 -23.0107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3985 -22.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5873 -22.3077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9241 -21.3198 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.0476 -21.3191 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8113 -24.4234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2199 -25.1312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4395 -22.3093 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6225 -22.2900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0169 -25.1751 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
6 1 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 2 0
5 20 2 0
15 21 1 0
21 22 3 0
7 23 1 0
23 24 1 0
10 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 398.22 | Molecular Weight (Monoisotopic): 397.0062 | AlogP: 2.81 | #Rotatable Bonds: 4 |
Polar Surface Area: 91.22 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.68 | CX Basic pKa: ┄ | CX LogP: 2.42 | CX LogD: 2.41 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.77 | Np Likeness Score: -0.79 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |